A placebo-controlled trial of the immune modulator, lentinan, in HIV- positive patients: A phase I/II trial

Journal of Medicine

Volumn 29, Issue 5-6, 1998, Pages 305-330

  Gordon, Maxwell ^c   Bihari, Bernard ^b   Goosby, Eric ^a   Gorter, Robert ^a   Greco, Mark ^a   Guralnik, Mario ^c   Mimura, Tohru ^d,e   Rudinicki, Valery ^a   Wong, Roberta ^a   Kaneko, Yutaro ^d  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b Community Research Initiative Inc ^*  (United States)

^c Glenpointe Centre West   (United States)

^d AJINOMOTO CO INC   (Japan)

^e Ajinomoto Pharmaceuticals USA Inc   (United States)

Author keywords

HIV positive patients; Immune modulator; Lentinan; Placebo controlled trial

Indexed keywords

DIDANOSINE; LENTINAN; ZIDOVUDINE;

ADULT; ANAPHYLAXIS; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GRANULOCYTOPENIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL;

ADJUVANTS, IMMUNOLOGIC; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIV INFECTIONS; HUMANS; INJECTIONS, INTRAVENOUS; LENTINAN; MALE; MIDDLE AGED; PLACEBOS; THROMBOCYTOPENIA;

EID: 6544262055     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Connaught's TheraCys (1990).: (BCG) U.S. Approval, World Pharmaceutical News. 1520: 28.
2. De Simone, C., Albertini, F., Almaviva, M., Angarano, G., Chiodo, F., Costigliola, P., Delia, S., Ferlini, A., Gritti, F. and Maxarello, G. (1989).: Clincial and immunologic assessment in HIV and subjects receiving inosine-pranobex; a randomized multicentric study. Med. Oncol. Tumor Pharmacother. 6: 63-67.
3. Fauci, A.S. (1990).: Sixth Int. Conf. on AIDS. June 20-24. San Francisco, CA.
4. 3. J. Med. 26: 193-207.
5. Kweder, S.L., Schnur, R.A. and Cooper, E.C. (1990).: Inosine pranobexis a single positive trial enough? N. Engl. J. Med. 322: 1807-1809.
6. Landay, A., Dittel, B., Urganski, P. (1989).: Effects of isoprinosine therapy on natural killer (NK) cells and antibody dependent cellular cytotoxicity (ADCC) in patients with HIV infection. Clin. Res. 37: 434A Abstract.
7. Ljungstrom, K.G., Renck, H., Strandberg, K., Hedin, H., Richter, W. and Widerlov, E. (1983).: Adverse reactions to dextran in Sweden 1970-1979. Acta Chir. Scand. 149: 253-262.
8. Matsuda, Judo (1990).: Personal Communication. Tokyo, Japan.
9. Moertel, C.G., Fleming, T.R., MacDonald, J.S., Haller, D.G., Laurie, J.A., Goodman, P.J. and Ungerleider, J.S. (1990).: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 322: 352-358.
10. Package insert for Rheomacrodex® (Dextran 40). Pharmacia Laboratories. Piscataway, NJ.
11. Pederson, C., Sandstrom, E., Peterson, C.S., Norkrans, G., Gerstoft, J., Karlsson, A., Christensen, K.C., Hakansson, C., Pehrson, P.O. and Nielsen, J.O. (1990).: The efficacy of inosine pranobex in preventing the acquired immuno-deficiency syndrome in patients with human immunodeficiency virus infection. N. Engl. J. Med. 322: 1757-1763.
12. Private Communication (1990).: Ajinomoto Co., Inc., Tokyo, Japan.
13. Renck, H., Ljungstrom, K.G., Hedin, H. and Richter, W (1983).: Prevention of dextran-induced anaphylactic reactions by hapten inhibition. A Scandinavian multicenter study on the effects of 20 ml. Dextran 1, 15% administered before Dextran 70 or Dextran 40. Acta Chir. Scand. 149: 355-360.
14. Ring, J. and Messmer, K. (1977).: Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet I: 466-469.
15. Rose, W.C., Read, F.C., Siminoff, P. and Bradner, W.T. (1984).: Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan. Cancer Res. 44: 1368-1373.
16. Taguchi, T. and Kaneko, Y. (1986).: Lentinan: An overview of experimental and clinical studies of its action against cancer. Proc. 7th Symp. on Host Defense Mechanisms Against Cancer. Hakone, Japan. Nov. 8-10.
17. Tochikura, T.S., Nakashima, H. and Kankeo, Y. (1987).: Suppression of human immunodeficiency virus replication by 3′-azido-3′-deoxy thymidine in various human hematopoietic cell lines in vitro: Augmentation of the effect by lentinan. Jpn. J. Cancer Res. (GAN N) 78: 583-589.
18. Wallace, J.I. and Bekesi, J.G. (1986).: A double-blind clinical trial of the effects of inosine pranobex in immunodepressed patients with prolonged generalized lymphadenopathy. Clin. Immunol. Immunopathol. 39: 179-186.
19. Witjes, J.A., Meijden, A.P. and Debruyne, F.M. (1990).: Use of intravesical bacillus Calmette-Guerin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. Urol. Int. 45: 129-136.
20. Yajima, Y., Satoh, J., Fukuda, I., Kikuchi, T. and Toyota, T. (1989).: Quantitative assay of lentinan in human blood with limulus colorimetric test. Tohoku J. Exp. Med. 157: 145-151.